Free tool
Diagnostics stocks
We cover 9 companies grouped under the Diagnostics theme. The median market value in the group is $331.49M. Across the group, the median move over the past trading day is +0.07%. Price change over the past year runs from −37.5% to +31.0% across the middle 80 percent of the group, with a median of −13.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| CSTL | Castle Biosciences, Inc. | $35.00 | +43.21% | −9.19% | +70.15% |
| IDX.AX | Integral Diagnostics Limited | 2.40 AUD | +15.38% | −3.07% | −17.78% |
| CEVI.ST | CellaVision AB (publ) | 167.40 SEK | +15.93% | +13.18% | −3.32% |
| ACL.AX | Australian Clinical Labs Limited | 2.89 AUD | +20.42% | +7.73% | +12.06% |
| YDES | YD Bio Ltd | $4.68 | +104.37% | −61.00% | −64.97% |
| 0RAR.L | Stratec SE | 23.05 EUR | +2.67% | +4.06% | −13.37% |
| XGN | Exagen Inc. | $7.60 | +72.73% | +25.83% | −22.84% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,862.00 JPY | +5.84% | +8.96% | +21.25% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.